ClinicalTrials.gg
RecruitingNCT07431892PEARLUpdated Feb 25, 2026

Pain Evaluation Across Robotic and Laparoscopic Surgery for Colorectal Procedures

An observational study in Minimally Invasive Surgical Procedures and Colon Cancer Patients, sponsored by Hospital Central de la Defensa Gómez Ulla. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-25.

Sponsored by Hospital Central de la Defensa Gómez Ulla · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Feb 2026, 8 months ago, but the record still lists the study as recruiting.
  • Started Sep 2025; still recruiting 1 year 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
80
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 86 studies in Pain, Postoperative with a site in Spain — 18 open to participants now, 23 under way, 1 of them phase 3. Pain, Postoperative · Spain.

Planned enrollment
19th of 26
80 · median 106
Started
2025
with 5 others
Observational
26 of 86
4 open now
Primary completion
2026-02
later than 11 of 22 live
Registered
76th of 86
by date

Among the 86 studies in Pain, Postoperative with a site in Spain, this one is the 19th largest by planned enrollment of the 26 observational ones that give a count, is one of 6 that started in 2025, is one of 26 observational ones, reaches primary completion later than 11 of the 22 other live ones, and was the 76th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

18 of the 86 studies in Pain, Postoperative with a site in Spain are open now. Recruiting first, the newest first:

12 more — sign in →

All 18 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 86 studies in Pain, Postoperative with a site in Spain, or all of them as a file.
02

Study summary

Minimally invasive surgery for colorectal conditions, such as laparoscopic or robotic surgery, has been shown to offer benefits over traditional open surgery. These benefits include less pain after surgery, shorter hospital stays, and fewer complications.

This study aims to compare two types of minimally invasive surgery-laparoscopic and robotic surgery-to determine which approach results in less postoperative pain for patients undergoing colon or rectal surgery. The central hypothesis is that robotic surgery, due to its higher precision and reduced tissue trauma, will lead to lower pain levels after surgery.

The study will enroll adult patients scheduled for elective colorectal surgery at the Hospital General Universitario Gregorio Marañón in Madrid. Participants will undergo either laparoscopic or robotic surgery based on clinical availability and surgical planning, as long as they meet all inclusion criteria under the hospital's enhanced recovery protocol (RICA program).

Researchers will assess patients' pain levels at different time points after surgery (immediately after recovery, at 24, 48, and 72 hours, and at discharge) using validated pain scales. The use of pain medications, hospital stay duration, complication rates, and quality of life up to 12 months after surgery will also be measured.

All patient data will be collected anonymously using a secure electronic system (REDCap). The study will last approximately 2 years and include about 80 patients (40 in each group).

The results could help surgeons and hospitals choose the most effective surgical approach to reduce postoperative pain and improve patient recovery in colorectal surgery.

Read the detailed description

This is a prospective, single-center, observational study conducted at the Hospital General Universitario Gregorio Marañón in Madrid, Spain. The study compares postoperative pain outcomes in patients undergoing elective colorectal surgery via two different minimally invasive surgical approaches: laparoscopic and robotic-assisted surgery.

Eligible participants will be adults (≥18 years) undergoing elective colon or rectal surgery for benign or malignant disease, provided they meet the criteria of the hospital's Enhanced Recovery After Surgery (ERAS) program, known locally as the RICA protocol. Patients with open surgery indications, chronic analgesic use, or other exclusion criteria (e.g., inflammatory bowel disease, multivisceral resections, chronic opioid use, or inability to follow the RICA protocol) will not be included.

Pain will be assessed using the Visual Analog Scale (VAS) at standardized time points: on arrival at the post-anesthesia care unit, upon admission to the surgical ward, and at 24, 48, and 72 hours postoperatively, as well as at discharge. Intraoperative nociception will also be evaluated using the Nociception Level Index (NOL), an objective measure that reflects the patient's pain response during surgery.

Additional outcomes include postoperative opioid consumption, length of hospital stay, complication rates (using the Clavien-Dindo classification), hospital readmissions, reintervention rates, and patient-reported quality of life measures at 1, 3, 6, and 12 months after surgery, using validated questionnaires (QLQ-C30, QLQ-CR29, and EQ-5D).

Data will be collected and stored securely using the REDCap electronic data capture system, ensuring patient confidentiality. The estimated sample size is 80 patients (approximately 40 in each group), and the total study duration is expected to be 2 years for recruitment and follow-up, with an additional period for data analysis and publication.

The goal is to generate high-quality evidence to help guide clinical decision-making in the selection of surgical approaches for colorectal surgery, focusing on reducing postoperative pain and enhancing recovery.

03

Conditions studied

  • Minimally Invasive Surgical Procedures
  • Colon Cancer Patients

Browse trials for

Keywords

  • colorectal surgery
  • minimally invasive surgery
  • robotic surgery
  • laparoscopic surgery
  • postoperative pain
  • Nociception Level Index (NOL)
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients (≥18 years) undergoing elective colorectal surgery (right or left colon resection) for malignant disease at the Hospital General Universitario Gregorio Marañón (Madrid, Spain), following the hospital's Enhanced Recovery After Surgery (ERAS) protocol (RICA program). All participants must meet strict inclusion criteria, including cognitive capacity and ASA I-III classification, and must consent to participate. Patients will receive either laparoscopic or robotic surgical approach based on surgical planning and equipment availability. The study will exclude individuals with prior chronic opioid use, certain comorbidities, or those requiring open surgery or multivisceral resection.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older
  • Signed
  • Meeting inclusion requirements of the hospital's Enhanced Recovery Protocol (RICA program), including:
  • Adequate cognitive status
  • ASA () classification I, II, or III
  • Elective colon surgery (right or left hemicolectomy) for malignant disease
  • Planned laparoscopic or robotic surgical approach
  • Preoperative evaluation completed as per RICA protocol (nutritional, nursing, anesthetic, and pharmacy assessments)

Exclusion criteria

Exclusion Criteria:

  • Patients with a preoperative decision for open surgery
  • Patients undergoing rectal surgery (partial or total mesorectal excision without protective stoma)
  • Patients with inflammatory bowel disease requiring colorectal resection
  • Patients requiring multivisceral resection due to oncologic indications identified intraoperatively
  • Extraction incision different from Pfannenstiel approach
  • Current or past history of chronic opioid use or opioid abuse
  • Current or past history of benzodiazepine use or abuse
  • Chronic use of analgesics for other comorbid medical conditions
  • Current or past history of recreational drug use or abuse
  • Non-compliance with the RICA protocol, including:
  • Lack of preoperative nutritional, nursing, anesthetic, or pharmacy evaluation
  • Non-adherence to preoperative care protocols (e.g., premedication, fasting, carbohydrate loading, thromboembolism prophylaxis, antibiotic prophylaxis, anesthetic care guidelines)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
80 participants (estimated)
Target follow-up
30 Days
Patient registry
Yes

Groups and cohorts

  • Laparoscopic Surgery

    Laparoscopic procedure

  • Robotic Surgery

    Robotic Procedure

06

What researchers measure

Primary outcomes

  1. Postoperative Pain

    Assessment of patient-reported postoperative pain at 24 hours after surgery, using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain).

    Time frame: 24 hours

Secondary outcomes

  1. Postoperative Pain at 48 Hours Measured by Visual Analog Scale (VAS)

    Assessment of patient-reported postoperative pain at 48 hours after surgery, using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain).

    Time frame: 48 hours post-surgery

  2. Postoperative Pain at 72 Hours Measured by Visual Analog Scale (VAS)

    Assessment of patient-reported postoperative pain at 72 hours after surgery, using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain).

    Time frame: 72 hours post-surgery

  3. Intraoperative Analgesic Consumption

    Total intraoperative consumption of opioids (fentanyl and remifentanil), recorded in micrograms, as an indirect measure of nociception and analgesic requirements during surgery.

    Time frame: Intraoperative period

  4. Postoperative Analgesic Consumption

    Total amount and type of analgesic medication administered during the postoperative hospital stay, including both scheduled and rescue analgesia.

    Time frame: From recovery room admission up to 72 hours after surgery.

  5. Postoperative Morbidity (Clavien-Dindo Classification)

    Incidence and severity of postoperative complications up to 30 days after surgery, categorized according to the Clavien-Dindo classification system. Patients without complications will be recorded as Grade 0. Complications will be graded from Grade I (minor deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic, or radiological interventions) to Grade V (death of the patient). The minimum possible value is 0 and the maximum possible value is V. Higher grades reflect greater severity of complications and therefore worse clinical outcomes.

    Time frame: Within 30 days after surgery

  6. Conversion Rate to Open Surgery

    Number and percentage of patients requiring conversion from laparoscopic or robotic approach to open surgery during the procedure.

    Time frame: Intraoperative period

  7. Postoperative Inflammatory Response

    Measurement of postoperative systemic inflammatory markers including C-reactive protein (CRP), at predefined postoperative time points (e.g., 24h and 48h).

    Time frame: Within the first 48 hours post-surgery

  8. Quality of Life (QoL) After Surgery

    Assessment of patient-reported quality of life using questionnaire EORTC QLQ-C30

    Time frame: 1 month post-surgery

  9. Quality of Life (QoL) After Surgery

    Assessment of patient-reported quality of life using questionnaire EORTC QLQ-C30

    Time frame: 3 month post-surgery

  10. Quality of Life (QoL) After Surgery

    Assessment of patient-reported quality of life using questionnaire EORTC QLQ-C30

    Time frame: 6 month post-surgery

  11. Postoperative Inflammatory Response

    Measurement of postoperative systemic inflammatory markers including procalcitonin at predefined postoperative time points (e.g., 24h and 48h).

    Time frame: Within the first 48 hours post-surgery

  12. Quality of Life (QoL) After Surgery

    Assessment of patient-reported quality of life using questionnaire EORTC QLQ-CR29

    Time frame: 1 month post-surgery

  13. Quality of Life (QoL) After Surgery

    Assessment of patient-reported quality of life using questionnaire EORTC QLQ-CR29

    Time frame: 3 month post-surgery

  14. Quality of Life (QoL) After Surgery

    Assessment of patient-reported quality of life using questionnaire EORTC QLQ-CR29

    Time frame: 6 month post-surgery

  15. Quality of Life (QoL) After Surgery

    Assessment of patient-reported quality of life using questionnaire EQ5D

    Time frame: 1 month post-surgery

  16. Quality of Life (QoL) After Surgery

    Assessment of patient-reported quality of life using questionnaire EQ5D

    Time frame: 3 month post-surgery

  17. Quality of Life (QoL) After Surgery

    Assessment of patient-reported quality of life using questionnaire EQ5D

    Time frame: 6 month post-surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared due to patient confidentiality concerns and institutional data protection policies. Additionally, the study is single-center with a limited sample size, and there is no formal data-sharing infrastructure or repository in place for this project.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Feb 2026, 5 months after the start.

Of 392 non-industry observational studies under Pain, Postoperative, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's planned 5 months is below that.

Counting every sponsor, half of 396 studies reached it within 13 months; a quarter within 6 and three quarters within 33.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 1, 2025
First posted
Feb 25, 2026
StartActual
Sep 1, 2025
Primary completionEst.
Feb 28, 2026
CompletionEst.
Sep 1, 2028
Last update
Feb 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07431892
Lead sponsor
Hospital Central de la Defensa Gómez Ulla
Responsible party
Patricia Tejedor (M.D., Ph.D., University Hospital Gregorio Marañón) — Principal investigator
First posted
Feb 25, 2026
Start date
Sep 1, 2025
Primary completion
Feb 28, 2026 (estimated)
Completion
Sep 1, 2028 (estimated)
Last update
Feb 25, 2026

Study contacts

Patricia Tejedor Patricia Tejedor, M.D., Ph.D.
Contact
tejedorpat@gmail.com
0034915 86 80 00
Joaquín Mascaró Joaquín Mascaró, M.D.
Contact
Patricia Tejedor Patricia Tejedor, M.D.,Ph.D.
principal investigator · University Hospital Gregorio Marañón

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion